 |
인쇄하기
취소
|
Keunwha to introduce new medicines for aphthous ulcers
Keunwha Pharm signed a license-in agreement with the US based Uluru Inc. to distribute Uluru’s two new drugs for the treatment of aphthous ulcers - Aphthasol Paste and OraDisk A.
Aphthasol Paste contains 5% amlexanox in an adhesive oral paste. Aphthasol is U.S FDA approved and indicated for the treatment of aphthous ulcers in people with normal immune systems.
OraDisc is a novel mucoadhe...
Aphthasol Paste contains 5% amlexanox in an adhesive oral paste. Aphthasol is U.S FDA approved and indicated for the treatment of aphthous ulcers in people with normal immune systems.
OraDisc is a novel mucoadhe...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.